HKEx (388.HK): US-Listed China ADR Homecoming, A Long-Term Positive
Chinese companies listed in the U.S. are following Alibaba Group (BABA US) in choosing Hong Kong for a secondary listing. It is reported that...
274 Views
Biolidics, iX Biopharma & Hyphens Pharma Outpace Peers in 2020 YTD
Singapore’s most traded primary-listed stocks that represent medical equipment manufacturing, biotech and pharmaceuticals all generated gains...
67 Views
Softbank Starts on Its ¥4.5trln Capital Plan - A Model for Bullishness
A bit over a year ago in early February 2019, Softbank Group (9984 JP) CEO Masayoshi Son went on a rant during the FYQ3 results announcement,...
360 Views
HSI Consultation on WVRs & Secondary Listings - BIG Flows
On 13 January, Hang Seng Indexes Limited (HSIL) released a consultation paper on proposed changes to the Hang Seng Index (HSI) and the Hang Seng...
319 Views
Softbank Group Q4: Details of Asset Restructuring Are Becoming Clear as Vision Fund Losses Mount
Softbank Group (9984 JP) Q4 and FY19 results came in slightly worse than its pre-announced guidance. This was the largest loss in Softbank's...
178 Views